Skip to content

Enact Holdings

US · ACT #1895 by market cap Listed 2021
45.82 -0.50 -1.08%
Live - 5344 symbols - heartbeat 173s ago · 2026-10-07 19:54
After-hours 45.82 0.00%
Market cap
6.30B
P/B
1.17
EPS
4.52
Reader sentiment Are you bullish or bearish on ACT?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Above fair value
27.79 fair value ≈ 33.74 39.69
  • Implied fair-value range of 27.79-39.69, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +35.8% above the average-multiple fair value of 33.74.

Valuation each multiple against its own 5-year range

P/B ratio 1.18 Expensive vs history 94th percentile
5-year average 1.01 · #11 of 14 in Insurance - Specialty
P/E ratio 9.75 Expensive vs history 95th percentile
5-year average 7.46 · forward 9.50 · #10 of 13 in Insurance - Specialty
P/S ratio 5.07 Expensive vs history 95th percentile
5-year average 4.08 · forward 4.97 · #15 of 15 in Insurance - Specialty

Vs. peers Insurance - Specialty

Company Market cap P/E (TTM) P/B Div yield
Enact Holdings (ACT) 6.30B 9.67 1.17 1.90%
Fidelity National Financial (FNF) 10.46B 13.60 1.40 5.28%
Axis Capital Holdings (AXS) 6.96B 6.79 1.17 1.85%
First American Financial (FAF) 6.26B 8.50 1.11 3.59%
Essent (ESNT) 5.56B 8.63 0.98 2.13%
MGIC Investment (MTG) 5.55B 8.46 1.11 2.22%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value47.59 Economic moatNone UncertaintyMedium

Trading 3.9% below Morningstar's fair value estimate.

Fair value

Enact Holdings Inc receives a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 4% discount to our quantitative fair value estimate of $47.59 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The company's valuation metrics bolster our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 86.3% lies in the top 40% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The firm's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's earnings yield of 10.7%, for example, sits in the top 20% compared with peers globally. This suggests that it is generating substantial earnings relative to its share price, which further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.

By Quantitative Equity Report

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.